 |
| june
1, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
|
BIG4BIO
WEEKLY CEO Q&A:
Robin Toft, CEO, Curebound |
| In
this Q&A, Robin talks about her career
pivot into the nonprofit sector, the
collaborative research model that sets
Curebound apart, the growing role of
philanthropic capital to fill funding
gaps, and what it takes to build both a
high-performing team and a research
accelerator with staying power. More |
|
|
- Ascentage Pharma: Data on
Olverembatinib in CML-LBP and Ph+ BCP-ALL at
ASCO 2026 More
- Ascentage Pharma: First Dataset on
MDM2-p53 Inhibitor Alrizomadlin (APG-115) in
Pediatric Solid Tumors at ASCO 2026 More
- Ascentage Pharma: Updated Clinical
Data for Olverembatinib as Second-Line
Therapy in CML-CP at ASCO 2026 More
- FDA: Issues Draft Guidance to Cut
Unnecessary Animal Testing for Cancer Drugs More
- Immunocore: Updated Phase 1 Data of
Brenetafusp in Patients With Heavily
Pretreated Advanced Melanoma More
- NextCure: Positive SIM0505 Phase 1 Dose
Escalation Data in Patients With Gynecologic
Cancers at ASCO 2026 More
- Precigen: New Long-Term Durability Data for
PAPZIMEOS, Recently Granted Seven-Year Market
Exclusivity, Demonstrating Complete Responses
Beyond 4 Years More
- Salubris Biotherapeutics: Updated Phase 1/2
Data for JK06, a 5T4-Targeted Antibody Drug
Conjugate, at the 2026 American Society of
Clinical Oncology Annual Meeting More
|
|
|
|
- From Seed to Series C: What Investors Look
for Beyond the Science More
|
|
 |
| Struggling
to get attention for your
products and services?
Break through with high-impact
marketing content and campaigns |
|
Learn More
→ |
|
|
- Big4Bio CEO Weekly Q&A: Robin
Toft, CEO, Curebound More
- Biotech Hangout: Episode 184 Podcast
- Can a Chaotic FDA Still Deliver on Faster
Drug Development? More
- FDA’s Next Fee Deal, Stacked With US
Incentives, Is Under White House Review More*
- FDA Publishes Two Final Guidances
for Industry on Bioequivalence More*
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
- AI in Biotech: The New Frontier for
Leadership & Strategy More
- David Chang to Hand Over the Reins at
Allogene; Ex-Esperion CEO Gets Started at
Phlow More*
- Congress Just Made Biotech Talent a National
Security Issue. Now Employers Need To Catch
Up. More
- Empowering Students Through STEM: A
Conversation With Massachusetts Science &
Engineering Fair Executive Director Helen
Rosenfeld More
- Hiring Outlook: Job Opportunities on
BioSpace Rise YOY, but Layoffs Affect
Thousands More
- More Than Executive Search: Building
Leadership for Every Stage of Growth More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Capital Region Life
Science Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Capital
Region, all rights reserved
2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
